Learn How to Buy Sosei Group Corporation Stock (JSS.F) Guide

yH5BAEAAAAALAAAAAAAABAAEAAAIBRAA7

Sosei Group Corporation discovers, develops and markets biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company’s product line consists of AZD4635, an adenosine A2a antagonist, which is in a phase II clinical trial for the treatment of metastatic castration-resistant prostate cancer and tumors; HTL0022562, a calcitonin gene-related peptide antagonist, which is in a preclinical stage for treating migraine and other severe headaches; PF-07081532 and PF-07054894, which are in Phase I for use in multiple therapeutic areas; HTL0014242, a small molecule negative allosteric modulator mGlu5, which is in a phase I clinical trial to treat neurological order; GPR35 agonist to treat inflammatory bowel disease; and KY1051, which is in the preclinical stage for immuno-oncology treatment. It also offers HTL0016878, an M4 muscarinic receptor agonist, which is in a phase I clinical trial for the treatment of Alzheimer’s disease; SSTR agonist, a new somatostatin peptide agonist, which is in a phase I clinical trial to treat endocrine disorders; GLP-1 antagonist, which is in the preclinical phase for the treatment of severe hypoglycemia in rare diseases; H4 antagonist, which is in the preclinical stage for the treatment of atopic dermatitis; EP4 antagonist, which is in the preclinical stage to mediate PGE2 immunosuppression; GLP-2 agonist, a potent glucagon-like peptide-2 agonist, in preclinical stage for treating intestinal disorders; GPR52 agonist for the treatment of neurological diseases; and mAb PAR2 for the treatment of atopic dermatitis. Sosei Group Corporation has a strategic partnership with Kymab; PeptiDream Inc; Pfizer; AbbVie; Biohaven; GSK; AstraZeneca; Novartis; Genetech; Takeda Pharmaceutical Company Limited; and Metrion Biosciences Limited. The company was established in 1990 and is headquartered in Tokyo, Japan. that it is in a preclinical stage to treat intestinal disorders; GPR52 agonist for the treatment of neurological diseases; and mAb PAR2 for the treatment of atopic dermatitis. Sosei Group Corporation has a strategic partnership with Kymab; PeptiDream Inc; Pfizer; AbbVie; Biohaven; GSK; AstraZeneca; Novartis; Genetech; Takeda Pharmaceutical Company Limited; and Metrion Biosciences Limited. The company was established in 1990 and is headquartered in Tokyo, Japan. that it is in a preclinical stage to treat intestinal disorders; GPR52 agonist for the treatment of neurological diseases; and mAb PAR2 for the treatment of atopic dermatitis. Sosei Group Corporation has a strategic partnership with Kymab; PeptiDream Inc; Pfizer; AbbVie; Biohaven; GSK; AstraZeneca; Novartis; Genetech; Takeda Pharmaceutical Company Limited; and Metrion Biosciences Limited. The company was established in 1990 and is headquartered in Tokyo, Japan. and Metrion Biosciences Limited. The company was established in 1990 and is headquartered in Tokyo, Japan. and Metrion Biosciences Limited. The company was established in 1990 and is headquartered in Tokyo, Japan.

Learn How to Buy Sosei Group Corporation Stock (JSS.F) Guide

Are you interested in obtaining shares of Sosei Group Corporation (JSS.F) in Frankfurt safely and through a regulated and reliable broker? Would you like to make your profits from the bank profitable and make profits on the stock market? Here I am going to show you how you can register with DEGIRO , a regulated investment broker with low commissions, and how you can get your first Sosei Group Corporation (JSS.F) (JSS.F) shares quickly and intuitively.

The step by step is easy to carry out :

  • To begin we are going to register in DeGiro, a platform where we will invest in shares of the company Corporación del Grupo Sosei (JSS.F) (JSS.F).
  • In the second step we will enter money and be able to make our 1st investment.
  • Once we have the funds we will locate Sosei Group Corporation using the ticker, which is JSS.F.
  • To finish we will only have to adjust the number of shares that we are going to obtain, the price and type of order.

Perhaps the checklist has been too basic for you, therefore I am going to explain the purchase process with images.

How to open an account at DeGiro.

As a first step we must register in degiro from this link :

buy shares of Sosei Group Corporation (JSS.F)

It will ask us for an e-mail, a username and a password to access, and later we will have to continue using the link that they have sent us by email address.

Now Degiro is going to require important information from us in order to validate our official identification . We need to have at hand our passport number, ID or driving document, our mobile phone and the bank account number that we will use to make our 1st deposit in IBAN format. If you don’t know what this format is like, you can check this simple step-by-step that we have done at Educacep.es .

stock Sosei Group Corporation

Once our account has been validated, we can pay money from the Deposit/Withdraw tab. We can carry out a bank transaction that will take 1 to 2 days, or make the deposit quickly using Sofort, a 100% secure and reliable payment gateway.

transfer money bank Sosei Group Corporation

How to buy Sosei Group Corporation (JSS.F) shares through Degiro

When we already have the capital we can get our first share. You can use the place order button that you will find in a corner or select the DEGIRO search engine and put the ticker. In the next screenshot you will find that I have put the Amazon Ticker but in your case you should put (JSS.F), the Sosei Group Corporation ticker. As we are talking about an action, we will see that the related businesses and companies are listed and there we will look at finding Sosei Group Corporation. The fundamental thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case Sosei Group Corporation (JSS.F) is listed on Frankfurt. This step is very essential so do not get confused.

real-time american stock exchange Sosei Group Corporation

At the time of making the order we have to pay special attention to the following . We can carry out a limit or market order. Imagine that you plan to get a share of Sosei Group Corporation, but its price is currently higher. With a limit order we are going to put the value at which we wish to make the acquisition and until there are no shares for sale at that value, the purchase of the share will not be executed. With a market order DeGiro will buy the number of shares that we have indicated at the true selling price, which is going to be very close to the current trading price.

limited order bbva Sosei Group Corporation (JSS.F)

In both cases it is very important that you look at the type of position: permanent or day . To give an example, in Spain, the stock market price is from tomorrow until 1 in the afternoon, and in the US it corresponds to the afternoon schedule in Spain. If an order is permanent, it will remain until it reaches execution, but if you choose the «of the day» option, at the end of the day, if it has not been executed, it will be removed from your Activity tab – Orders in process.

I would love that this detailed post has helped you to invest in Sosei Group Corporation.

  Company information
  • Sosei Group Corporation Address (JSS.F): PMO Hanzomon 11th Floor 2-1 Kojimachi Chiyoda-ku Tokyo 102-0083 Japan 81 3 5210 3290 – Website: http://soseiheptares.com
  • Ticker: JSS.F
  • Industry: Unknown
  • Industry: Biotechnology
  • Number of employees: 193
  • Listed market: Frankfurt

key executives

Name Title Salary exercised Year of birth
Mr. Shinichi Tamura Founder, Exec. President, Executive Representative Officer, President and CEO 1.17 million N/A 1949
Dr Malcolm Weir Exec. Vice president 695.77k N/A 1958
Mr Chris Cargill COO and CFO of the group 713.84k N/A 1984
Dr Rob Cooke Head of Technology N/A N/A N/A
Dr Miles Congreve Scientific Director N/A N/A N/A
Mr. Hironoshin Nomura Senior Vice President of Investor Relations and Corporate Strategy N/A N/A N/A
Mr. Kazuhiko Yoshizumi Exec. Group Vice President and Chief Compliance Officer N/A N/A 1954
Candelle Chong Vice President of Strategy and Corporate Communications N/A N/A N/A
Dr Tim Tasker Exec. Vice President and Medical Director N/A N/A 1964
Shinichiro Nishishita Vice President of Investor Relations and Head of Regulatory Disclosures N/A N/A N/A

Recent events of :

We have no recent events for this company.